OBESITY OR OVERWEIGHT

Clinical trials for OBESITY OR OVERWEIGHT explained in plain language.

Never miss a new study

Get alerted when new OBESITY OR OVERWEIGHT trials appear

Sign up with your email to follow new studies for OBESITY OR OVERWEIGHT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 5 Not yet recruiting 1 Not yet finished but already full! 2 Completed 5

New obesity drug switch trial aims to keep weight off Long-Term

Disease control Not yet recruiting

This study tests whether switching from popular weight-loss drugs (GLP-1 receptor agonists) to a new medication called maridebart cafraglutide can help adults with obesity or overweight maintain weight loss. About 300 participants who have already lost at least 10% of their body …

Matched conditions: OBESITY OR OVERWEIGHT

Phase: PHASE3 • Sponsor: Amgen • Aim: Disease control

Last updated May 14, 2026 12:04 UTC

OBESITY OR OVERWEIGHT

Get alerted when new OBESITY OR OVERWEIGHT trials appear

New obesity drug switch trial aims to keep weight off Long-Term